Live Breaking News & Updates on Lp 284

Stay updated with breaking news from Lp 284 . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Grants Orphan Drug Designation to LP-284 for High-Grade B-Cell Lymphomas

The FDA has granted orphan drug designation to LP-284 for use in the treatment of patients with high-grade B-cell lymphoma harboring MYC and BCL2 rearrangements. ....

United States , Lantern Pharma Inc , Lantern Pharma , Lp 284 , High Gradeb Cell Lymphoma , Blood Cancer , Precision Med , Myc And Bcl2 Rearrangements , Orphan Drug Designation , Next Generation Acylfulvene ,